Melanoma (Skin) [clinicaltrials_resource:dc217a80725f55620163e20ba3cf2746]
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma [clinicaltrials:NCT00002455]Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00002535]Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002669]Biological Therapy in Treating Patients With Metastatic Cancer [clinicaltrials:NCT00002733]Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [clinicaltrials:NCT00002754]High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma [clinicaltrials:NCT00002763]Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002767]Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma [clinicaltrials:NCT00002781]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002786]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002817]Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002845]SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002860]Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma [clinicaltrials:NCT00002892]Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002947]clinicaltrials:NCT00002952Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00002973]Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer [clinicaltrials:NCT00003022]Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003027]Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003060]High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma [clinicaltrials:NCT00003091]clinicaltrials:NCT00003222clinicaltrials:NCT00003224Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal [clinicaltrials:NCT00003229]Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery [clinicaltrials:NCT00003274]Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma [clinicaltrials:NCT00003308]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003346]Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00003362]Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin [clinicaltrials:NCT00003444]Antineoplaston Therapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00003509]Vaccine Therapy in Treating Patients With Melanoma [clinicaltrials:NCT00003556]Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003568]Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome [clinicaltrials:NCT00003601]clinicaltrials:NCT00003641Vaccine Therapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00003665]Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003690]Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma [clinicaltrials:NCT00003715]Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma [clinicaltrials:NCT00003747]clinicaltrials:NCT00003750Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003792]
condition [clinicaltrials_vocabulary:condition]
Melanoma (Skin) [clinicaltrials_resource:dc217a80725f55620163e20ba3cf2746]
Bio2RDF identifier
dc217a80725f55620163e20ba3cf2746
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:dc217a80725f55620163e20ba3cf2746
identifier
clinicaltrials_resource:dc217a80725f55620163e20ba3cf2746
title
Melanoma (Skin)
@en
label
Melanoma (Skin) [clinicaltrials_resource:dc217a80725f55620163e20ba3cf2746]
@en